(Q44376216)

English

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

erectile dysfunction

1 reference

based on heuristic

inferred from title

Wayne J G Hellstrom

1

object named as

Wayne J G Hellstrom

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Marc Gittelman

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Gary Karlin

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Thomas Segerson

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Marc Thibonnier

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Terry Taylor

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Harin Padma-Nathan

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Vardenafil Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8-14

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of oral and intracavernosal vasoactive agents in penile erection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Future considerations: advances in the surgical management of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral pharmacotherapy for erectile dysfunction: current perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900115-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(03)00115-8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44376216&oldid=2020580428"